NCT05831293

Brief Summary

The participants consisted of 1332 caregivers of patients diagnosed with cancer, who applied to Atatürk University Health Research and Application Center, Outpatient Chemotherapy Unit between December 2022 and March 2023. In the power analysis, the sample of the research; According to Cohen, a total of 108 people, 54 of whom were in the experimental group and 54 in the control group, with a medium effect size of 0.5%, an error margin of 0.05% and a confidence interval of 0.95%, were 95% representative of the universe. Against the possibility of data loss, 20% backup sample was included in this number and the study was planned with a total of 124 people, 62 in the experimental group and 62 in the control group. 20 participants were excluded on the basis of inclusion and exclusion criteria. 104 participants formed the sample

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable cancer

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 14, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 26, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2023

Completed
Last Updated

November 2, 2023

Status Verified

November 1, 2023

Enrollment Period

2 months

First QC Date

April 14, 2023

Last Update Submit

November 1, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Caregiver Stress Scale

    The scale was developed by Robinson (1983) to measure the subjective care burden of caregivers and to quickly identify families with care concerns. Its Turkish adaptation was made by Uğur and Fadıloğlu (2006). The reliability coefficient of the scale was found to be 0.77. The scale consists of 13 items. The scoring of the scale is between 0-1. A score above 7 indicates the burden of care subjectively.

    two week

  • The Caregiver Quality of Life Index Cancer Scale -CQOLC

    It was developed by Weitzner et al. to measure the quality of life of caregivers of cancer patients, including physical function, emotional function, family function, and social function. The total score of each sub-dimension and scale in the scale varies between 0 and 140. A higher score indicates a better quality of life.

    Two week

Study Arms (2)

Experimental

EXPERIMENTAL

In each session, three sections were discussed and reviewed: (1) last week's experiences, (2) training, and (3) practice. Each session usually began with mindfulness and meditation exercises, followed by group discussion, review of homework activities, and introduction to new exercises. Participants were asked to complete 15-30 minutes of daily practice each week.

Behavioral: Mindfulness Based Stress Reduction Program

Control

NO INTERVENTION

No intervention will be applied to the control group.

Interventions

In each session, three sections were discussed and reviewed: (1) last week's experiences, (2) training, and (3) practice. Each session usually began with mindfulness and meditation exercises, followed by group discussion, review of homework activities, and introduction to new exercises. Participants were asked to complete 15-30 minutes of daily practice each week.

Experimental

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • No psychiatric problems,
  • Over 18,
  • literate,
  • Having internet access at home,
  • Not receiving or planning to receive therapy support during the education process,
  • Not having any previous mindfulness experience

You may not qualify if:

  • Those who want to leave the study,
  • Do not accept to participate in the research
  • not at a level to answer the questions asked cognitively.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ataturk Unıversity

Erzurum, 25240, Turkey (Türkiye)

Location

Ataturk Unıversity

Erzurum, Turkey (Türkiye)

Location

MeSH Terms

Conditions

NeoplasmsCaregiver Burden

Condition Hierarchy (Ancestors)

Stress, PsychologicalBehavioral SymptomsBehavior

Study Officials

  • Nihan Türkoğlu, Assist.Prof.

    Ataturk University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assist Prof.

Study Record Dates

First Submitted

April 14, 2023

First Posted

April 26, 2023

Study Start

January 15, 2023

Primary Completion

March 15, 2023

Study Completion

September 15, 2023

Last Updated

November 2, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations